Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Preferred Shares Issued: 2016-2018

Historic Preferred Shares Issued for Crinetics Pharmaceuticals (CRNX) over the last 3 years, with Dec 2018 value amounting to $63.3 million.

  • Crinetics Pharmaceuticals' Preferred Shares Issued fell 99.88% to $9,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $70.5 million, marking a year-over-year change of. This contributed to the annual value of $63.3 million for FY2018, which is 428.66% up from last year.
  • Latest data reveals that Crinetics Pharmaceuticals reported Preferred Shares Issued of $63.3 million as of FY2018, which was up 428.66% from $12.0 million recorded in FY2017.
  • Crinetics Pharmaceuticals' Preferred Shares Issued's 5-year high stood at $63.3 million during FY2018, with a 5-year trough of -$5,000 in FY2016.
  • Its 3-year average for Preferred Shares Issued is $25.1 million, with a median of $12.0 million in 2017.
  • Data for Crinetics Pharmaceuticals' Preferred Shares Issued shows a peak YoY spiked of 239,480.00% (in 2017) over the last 5 years.
  • Crinetics Pharmaceuticals' Preferred Shares Issued (Yearly) stood at -$5,000 in 2016, then spiked by 239,480.00% to $12.0 million in 2017, then skyrocketed by 428.66% to $63.3 million in 2018.